NovoRapid Flexpen
Brand Name: NovoRapid Flexpen
Generic Name: Insulin Aspart
Active
Registration Number
BR-1074
Dosage Form
Solution For Injection (SC)
Issuance Date
March 31, 2025
Expiry Date
March 20, 2031
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100 U/mL
Packaging3 mL Solution in a Cartridge (Type I Glass) with a Bromobutyl Plunger and a Bromobutyl/Polyisoprene Stopper contained in a Pre-filled Multidose Disposable Pen made of Polypropylene (Box of 5's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Insulins and Analogues
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Insulin AspartActive
Monograph: Insulin aspart